Southern Research Institute today announced that Arthur J. Tipton, Ph.D., has been selected by its Board of Directors to serve as president and CEO of Southern Research effective July 8, 2013.
Tipton replaces John A. “Jack” Secrist, III, Ph.D., who served as president and CEO of Southern Research Institute for seven years. Secrist announced his retirement earlier this year after 34 years of service at Southern Research.
“The Board is extremely pleased that Dr. Tipton will lead Southern Research Institute, and I look forward to working with him,” said Ray L. Watts, M.D., president of the University of Alabama at Birmingham, and chairman of the Southern Research Board of Directors. “This is a critical time for research, with both opportunities and challenges, and his experience and strategic vision are ideal to grow the organization’s portfolio of contract research in biomedical science, drug discovery and advanced technology/engineering.”
Tipton previously served as senior vice president and general manager of Evonik— Birmingham Laboratories in Birmingham, Ala. During his career, he has helped lead the growth of three pharmaceutical/biotech companies and launched four commercial products. He holds 31 U.S. patents with numerous foreign equivalents, and he has more than 70 publications, presentations and invited lectures to his credit.